Search Results - Giné, Eva

Refine Results
  1. 1
    Development of Survival Responsiveness to Brain-Derived Neurotrophic Factor, Neurotrophin 3 and Neurotrophin 4/5, But Not to Nerve Growth Factor, in Cultured Motoneurons from Chick Embryo Spinal Cord

    Development of Survival Responsiveness to Brain-Derived Neurotrophic Factor, Neurotrophin 3 and Neurotrophin 4/5, But Not to Nerve Growth Factor, in Cultured Motoneurons from Chick... by Becker, Elena, Soler, Rosa M., Yuste, Víctor J., Giné, Eva, Sanz-Rodríguez, César, Egea, Joaquim, Martín-Zanca, Dionisio, Comella, Joan X.

    Published 1998
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia

    Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia by Mozas, Pablo, Rivas-Delgado, Alfredo, Baumann, Tycho, Villamor, Neus, Ortiz-Maldonado, Valentín, Aymerich, Marta, Costa, Dolors, Navarro, Alba, Giné, Eva, López-Guillermo, Armando, Montserrat, Emili, Delgado, Julio

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy

    Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy by Rovira, Jordina, Valera, Alexandra, Colomo, Lluis, Setoain, Xavier, Rodríguez, Sonia, Martínez-Trillos, Alejandra, Giné, Eva, Dlouhy, Ivan, Magnano, Laura, Gaya, Anna, Martínez, Daniel, Martínez, Antonio, Campo, Elías, López-Guillermo, Armando

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior

    Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinic... by Giné, Eva, Martinez, Antoni, Villamor, Neus, López-Guillermo, Armando, Camos, Mireia, Martinez, Daniel, Esteve, Jordi, Calvo, Xavier, Muntañola, Ana, Abrisqueta, Pau, Rozman, Maria, Rozman, Ciril, Bosch, Francesc, Campo, Elias, Montserrat, Emili

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience

    Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience by Mozas, Pablo, Nadeu, Ferran, Rivas-Delgado, Alfredo, Rivero, Andrea, Garrote, Marta, Balagué, Olga, González-Farré, Blanca, Veloza, Luis, Baumann, Tycho, Giné, Eva, Delgado, Julio, Villamor, Neus, Campo, Elías, Magnano, Laura, López-Guillermo, Armando

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status

    The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational sta... by Vidal-Crespo, Anna, Rodriguez, Vanina, Matas-Cespedes, Alba, Lee, Eriong, Rivas-Delgado, Alfredo, Giné, Eva, Navarro, Alba, Beà, Sílvia, Campo, Elias, López-Guillermo, Armando, Lopez-Guerra, Monica, Roué, Gaël, Colomer, Dolors, Pérez-Galán, Patricia

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?

    Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin? by Magnano, Laura, Navarro, Alba, López-Guerra, Mónica, Clot, Guillem, Beà, Sílvia, Bastidas, Gabriela, Costa, Dolors, Rivero, Andrea, Garrote, Marta, Giné, Eva, Rozman, María, Aymerich, Marta, Colomer, Dolors, López-Guillermo, Armando, Campo, Elías, Villamor, Neus, Matutes, Estella

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact

    Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact by Mozas, Pablo, Piñeyroa, Juan A., Nadeu, Ferran, Magnano, Laura, Rivero, Andrea, Rivas-Delgado, Alfredo, Bataller, Alex, Fabregat, Aleix, Giné, Eva, Baumann, Tycho, Villamor, Neus, Aróstegui, Juan Ignacio, Aymerich, Marta, López-Guillermo, Armando, Campo, Elías, Delgado, Julio

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma

    Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma by Rivas-Delgado, Alfredo, Nadeu, Ferran, Andrade-Campos, Marcio, López, Cristina, Enjuanes, Anna, Mozas, Pablo, Frigola, Gerard, Colomo, Luis, Sanchez-Gonzalez, Blanca, Villamor, Neus, Beà, Sílvia, Campo, Elías, Salar, Antonio, Giné, Eva, López-Guillermo, Armando, Bellosillo, Beatriz

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance

    Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance by Garcia-Vidal, Carolina, Cardozo-Espinola, Celia, Puerta-Alcalde, Pedro, Marco, Francesc, Tellez, Adrian, Agüero, Daiana, Romero-Santana, Francisco, Díaz-Beyá, Marina, Giné, Eva, Morata, Laura, Rodríguez-Núñez, Olga, Martinez, Jose Antonio, Mensa, Josep, Esteve, Jordi, Soriano, Alex

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

    Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma by Dang, Nam H., Ogura, Michinori, Castaigne, Sylvie, Fayad, Luis E., Jerkeman, Mats, Radford, John, Pezzutto, Antonio, Bondarenko, Igor, Stewart, Douglas A., Shnaidman, Michael, Sullivan, Sharon, Vandendries, Erik, Tobinai, Kensei, Ramchandren, Radhakrishnan, Hamlin, Paul A., Giné, Eva, Ando, Kiyoshi

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy

    The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy by Santacruz, Rodrigo, Villamor, Neus, Aymerich, Marta, Martínez-Trillos, Alejandra, López, Cristina, Navarro, Alba, Rozman, María, Beà, Sílvia, Royo, Cristina, Cazorla, Maite, Colomer, Dolors, Giné, Eva, Pinyol, Magda, Puente, Xose S., López-Otín, Carlos, Campo, Elías, López-Guillermo, Armando, Delgado, Julio

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry

    Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry by Tilch, Marie-Kristin, Visco, Carlo, Kinda, Sandra, Hermine, Olivier, Kohn, Milena, Besson, Caroline, Lamure, Sylvain, Duléry, Rémy, Ragaini, Simone, Eyre, Toby A., Van Meerten, Tom, Ohler, Anke, Eckerle, Steffen, Dreyling, Martin, Hess, Georg, Giné, Eva, Gomes da Silva, Maria

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma

    Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma by Fuster, Carla, Martín-Garcia, David, Balagué, Olga, Navarro, Alba, Nadeu, Ferran, Costa, Dolors, Prieto, Miriam, Salaverria, Itziar, Espinet, Blanca, Rivas-Delgado, Alfredo, Terol, Maria José, Giné, Eva, Forcada, Pilar, Ashton-Key, Margaret, Puente, Xose S., Swerdlow, Steven H., Beà, Sílvia, Campo, Elias

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution

    Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a S... by Rivero, Andrea, Mozas, Pablo, Jiménez, Laura, López-Guerra, Mónica, Colomer, Dolors, Bataller, Alex, Correa, Juan, Rivas-Delgado, Alfredo, Bastidas, Gabriela, Baumann, Tycho, Martínez-Trillos, Alejandra, Delgado, Julio, Giné, Eva, Campo, Elías, López-Guillermo, Armando, Villamor, Neus, Magnano, Laura, Matutes, Estella

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    SOX11, CD70, and T(reg) cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma

    SOX11, CD70, and T(reg) cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma by Balsas, Patricia, Veloza, Luis, Clot, Guillem, Sureda-Gómez, Marta, Rodríguez, Marta-Leonor, Masaoutis, Christos, Frigola, Gerard, Navarro, Alba, Beà, Silvia, Nadeu, Ferran, Giné, Eva, López-Guillermo, Armando, Martínez, Antonio, Ribera-Cortada, Inmaculada, Engel, Pablo, Quintanilla-Martínez, Leticia, Klapper, Wolfram, Campo, Elias, Amador, Virginia

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evaluating the Immunoconjugate Inotuzumab Ozogamicin With Rituximab

    Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evalua... by Fayad, Luis, Offner, Fritz, Smith, Mitchell R., Verhoef, Gregor, Johnson, Peter, Kaufman, Jonathan L., Rohatiner, Ama, Advani, Anjali, Foran, James, Hess, Georg, Coiffier, Bertrand, Czuczman, Myron, Giné, Eva, Durrant, Simon, Kneissl, Michelle, Luu, Kenneth T., Hua, Steven Y., Boni, Joseph, Vandendries, Erik, Dang, Nam H.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia

    The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia by Matas-Céspedes, Alba, Vidal-Crespo, Anna, Rodriguez, Vanina, Villamor, Neus, Delgado, Julio, Giné, Eva, Roca-Ho, Heleia, Menéndez, Pablo, Campo, Elías, López-Guillermo, Armando, Colomer, Dolors, Roué, Gaël, Wiestner, Adrian, Parren, Paul W.H.I., Doshi, Parul, van Bueren, Jeroen Lammerts, Pérez-Galán, Patricia

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens

    Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens by Vidal-Crespo, Anna, Matas-Céspedes, Alba, Rodriguez, Vanina, Rossi, Cédric, Valero, Juan G., Serrat, Neus, Sanjuan-Pla, Alejandra, Menéndez, Pablo, Roué, Gaël, López-Guillermo, Armando, Giné, Eva, Campo, Elías, Colomer, Dolors, Bezombes, Christine, van Bueren, Jeroen Lammerts, Chiu, Christopher, Doshi, Parul, Pérez-Galán, Patricia

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma

    A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma by Demajo, Santiago, Albero, Robert, Clot, Guillem, Castellano, Giancarlo, Navarro, Alba, Capdevila, Cristina, Enjuanes, Anna, Nadeu, Ferran, Giné, Eva, Pinyol, Magda, Jaffe, Elaine S., Ott, German, Staudt, Louis M., Rosenwald, Andreas, Scott, David W., Rimsza, Lisa M., López-Guillermo, Armando, Beà, Sílvia, Campo, Elias, Jares, Pedro

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: